ReproNovo ApS

2 trials 1 recruiting Commercial sponsor

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

1 Recruiting

0 Completed trials

2 Countries active

1 Unique IMPs

N/A Results reported

Phase II

Phase I (Other)

Phase II: 1 Phase I (Other): 1

Top IMPs

All trials

2 total

Trial evaluating the pharmacodynamics of two dosing regimens of nolasiban Pending

2025-524896-22-00 Phase II 1 country NOLASIBAN
To evaluate the pharmacokinetics and safety of nolasiban Recruiting

2025-523706-32-00 Phase I (Other) 1 country

Showing 1–2 of 2 trials

← All sponsors A–Z